Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Pain, Acute PostoperativeRenal Stone
Interventions
DRUG

Active bupivacaine 0.25% via an erector spinae plane perineural catheter

Administration of bupivacaine 0.25% through a perineural catheter inserted into the erector spinae plane (programmed intermittent bolus of 21 mL every 4 hours and no patient-controlled bolus)

DRUG

Placebo normal saline via an erector spinae plane perineural catheter

Administration of normal saline through a perineural catheter inserted into the erector spinae plane (programmed intermittent bolus of 21 mL every 4 hours and no patient-controlled bolus)

Trial Locations (2)

92103

UC San Diego, San Diego

University of California, San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER